fda and compounded glp 1 🚨There's been a lot of confusion lately, so let's clear this up… GLP-1 medications (like semaglutide tirzepatide) are not banned entirely — but access is changing. The has ended Compound versions of GLP-1 drugs

Brain neuroimaging studies and enzymatic, transcriptomic and proteomic analyses of the autistic brain further support forms of mitochondrial dysfunction in the central nervous system (5157)

Research describes upregulation of the growth-hormone receptor and modulation of nitric oxide signalling, alongside effects on VEGF-driven angiogenesis that may support the formation of new blood vessels

The behavioral effects on eating are well-documented in clinical literature: Dramatically reduced portion sizes: Clinical trials show semaglutide users lose an average of 1315% of body weight and tirzepatide users 1722%, driven largely by significant reductions in portion size and overall food intake

However, patients must initiate the conversation with their doctor, which may present a barrier if they lack an established relationship or if their provider is unfamiliar with GLP-1 compounding

24 , 140.e1140.e5 (2020)